PedsCases Podcast Scripts

Similar documents
Urticaria and Angioedema. Allergy and Immunology Awareness Program

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI

Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria

PedsCases Podcast Scripts

REFERRAL GUIDELINES - SUMMARY

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics

Eczema: also called atopic dermatitis; a chronic, itchy, scaly rash not due to a particular substance exposure

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital

Immunology. Lecture- 8

VACCINE-RELATED ALLERGIC REACTIONS

Urticaria. Appearance. Epidemiology [1] Aetiology [2]

Managing urticaria in primary care

FIT Board Review Corner April 2017

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals.

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012

PedsCases Podcast Scripts

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Allergy Medicine James MacLean, M.D.

Allergic Emergencies and Anaphylaxis. George Porfiris MD, CCFP(EM),FCFP TEGH

DOES URTICARIA RULE YOUR LIFE?

Allergy Medicine James MacLean, M.D.

Update on urticaria Associate Professor Rohan Ameratunga Adapted for New Zealand from GLORIA Module 12: Urticaria

Allergic Conditions in Sports. Seth Smith, MD, CAQ-SM, PharmD TPC Course February 7, 2016

VACCINE-RELATED ALLERGIC REACTIONS

Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen

CHRONIC URTICARIA; IT S MORE THAN JUST ANTIHISTAMINES!

The Diagnosis and Management of Anaphylaxis

Acute urticaria in children - management. Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital

Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND

OBJECTIVES DEFINITION TYPE I HYPERSENSITIVITY TYPES OF HYPERSENSITIVITY ACUTE ALLERGIC REACTION 11/5/2016

Immunologic Mechanisms of Tissue Damage. (Immuopathology)

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

Anaphylaxis: The Atypical Varieties

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

By the end of this lecture physicians will:

Paediatric Food Allergy. Introduction to the Causes and Management

The management of chronic urticaria in primary care for adults and children

Five things to know about anaphylaxis

XOLAIR (omalizumab) Prior Authorization

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local

Transfusion and Allergy: What is it, and what is it not? Prof. Olivier GARRAUD INTS, Paris Université de Lyon/Saint-Etienne France

Xolair. Xolair (omalizumab) Description

1

Al ergy: An Overview

Anti-allergic Effect of Bee Venom in An Allergic Rhinitis

Xolair. Xolair (omalizumab) Description

PedsCases Podcast Scripts

Food Allergy , The Patient Education Institute, Inc. imf10101 Last reviewed: 10/15/2017 1

Nursing Services Fall 2011

Systemic Allergic & Immunoglobulin Disorders

Allergy Management Policy

Idiopathic Anaphylaxis. Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)

Urticaria and Angioedema

Chronic urticaria information leaflet

Allergy Awareness & EpiPen Administration

MANAGING COMMON PRESENTATIONS OF ALLERGY IN PRIMARY CARE. Helen Bourne Consultant Immunologist

Eosinophilic Esophagitis. Kristine J. Krueger M.D. June 2014

Food allergy in children. nice bulletin. NICE Bulletin Food Allergy in Chlidren.indd 1

Food-allergy-FINAL.mp3. Duration: 0:07:39 START AUDIO

How to Successfully Manage Chronic Urticaria? & Tall Tales from Texas

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria

FDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food

Allergy Glossary of Terms

Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host.

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Referral to Allergy clinic: ADULTS (and children 16 years and older)

Anaphylaxis in the Community

Glossary of Terms ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Food Allergies. (Demkin). That is approximately two million kids. That number only represents children, but

Allergy Skin Prick Testing

Allergic Reactions and Envenomations. Chapter 16

Cigna Drug and Biologic Coverage Policy

Hypersensitivity diseases

Managing Penicillin Allergy

West Houston Allergy & Asthma, P.A.

Emergency Preparedness for Anaphylaxis in School

Anaphylaxis School First results of a national multicenter study

Rand E. Dankner, M.D. Jacqueline L. Reiss, M. D.

Itch and Swelling update: Practical Approach to Urticaria & Angioedema

Foundations in Microbiology Seventh Edition

DNA vaccine, peripheral T-cell tolerance modulation 185

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?

HYPERSENSITIVITY REACTIONS D R S H O AI B R AZ A

Pediatric Allergy Allergy Related Testing

Michaela Lucas. Clinical Immunologist/Immunopathologist. Pathwest, QE2 Medical Centre, Princess Margaret Hospital

Anti-IgE: beyond asthma

Skin prick testing: Guidelines for GPs

An unpredictable, dose-independent adverse drug reaction which is immunologically or IgEmediated.

Asthma With a Slight Chance of Anaphylaxis

Anaphylaxis: Treatment in the Community

IMMUNOLOGY. Referral Guidelines NATIONAL REFERRAL GUIDELINES : IMMUNOLOGY. As above Specialist assessment is essential.

Immunocompetence The immune system responds appropriately to a foreign stimulus

The proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY

Transcription:

PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Urticaria These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio versions are accessible on itunes or at www.pedcases.com/podcasts. Urticaria Introduction: Hi everyone, my name is Dayae Jeong and I am a medical student at McMaster University in Ontario, Canada. This PedsCases podcast on urticaria was developed with the help of Dr. Wade Watson, a pediatric allergist, professor of pediatrics, Dalhousie University, and head of the Division of Allergy at IWK Children s Hospital. This podcast is designed to give you an overview of urticaria. We will be addressing the following questions in our podcast: 1. What is urticaria? 2. What is the pathophysiology of urticaria, and what causes it? 3. How is urticaria classified? 4. How do you diagnose urticaria? 5. What are the management options for urticaria? Defining Urticaria Let s start with a case. You are a 3 rd year medical student working in a general pediatrician s office, and asked to see Jimmy. Jimmy is a 6-year-old boy who is being brought in by his mother because he broke out in hives a few days ago. Urticaria, more commonly known as hives, is a term used to describe mast cell and basophil mediated pruritic skin lesions. It presents with raised, red or pink lesions that have wheals (pale centers). These lesions are polymorphous, so they may be round or irregularly shaped. They can range in size from a few millimeters to a few centimeters. Typically, they disappear within 48 hours of appearing but may reappear 1,2.

Pathophysiology and Etiologies of Urticaria Urticaria is caused by degranulation of mast cells and basophils. Both types of cells are members of the innate immune system, and primarily located in the skin and mucosa. Degranulation releases many inflammatory mediators such as histamine, leukotrienes, and prostaglandins, into the surrounding space and induce vasodilation. The resulting influx of plasma into and below the skin and mucosa is what causes the swelling and redness associated with urticaria. Histamine also binds to itch receptors of the nervous system, causing pruritus. Sometimes, there is a delayed release of additional inflammatory cytokines such as tumor-necrosis-factor, interleukin 4 and interleukin 5, over the next 4-8 hours, leading to a prolonged reaction 1,3. We can divide the factors that cause degranulation of mast cells and basophils into those which are immunologically mediated and those which are not. Among immunologically mediated factors, there is a further divide between IgE antibody mediated and non-ige mediated urticaria 1. IgE-mediated immunologic reactions occur on exposure to antigens that have associated IgE antibodies in the body. IgE antibodies tend to be located on mast cell surfaces, and cluster together when they are bound by their antigens, leading to degranulation. In many, cases, these antigens are allergens including aeroallergens, contact, food, and drug allergens. Common food allergens in Canada include milk, eggs, peanuts, tree nuts, fish and shellfish. Common drug allergens are antibiotics in the beta-lactam class, particularly penicillin. Non-allergen antigens include insect venom and parasites 1,4 6 Next, non-ige mediated immunologic reactions result when components of the immune system other than IgE antibodies trigger degranulation. In fact, urticaria in children is most commonly caused by viral infections such as rhinovirus, rotavirus and EBV. These infections activate the complement system to trigger degranulation. Non-IgE mediated immunologic reactions may also involve auto-antibodies in the context of autoimmune diseases like lupus, vasculitides, rheumatoid arthritis, Sjogren s syndrome, celiac disease and lymphoma. Lastly, mastocytosis is a condition of an increased number of mast cells, and would also fit in this category 1,4. Finally, non-immunologic urticaria results when the inciting agent directly causes mast cell and basophil degranulation. Medications in this category are aspirin, NSAIDs, vancomycin, and opiates. Foods in this category include those with large amounts of salicylates or histamine. Many fruits have a high concentration of salicylates, and improperly stored fish can accumulate high levels of histamine from bacterial metabolism. Finally, physical triggers for urticaria belong in this category. These include pressure on the skin (also known as dermatographism), rises in basal body temperature from exercise or heat (cholinergic urticaria), exposure to cold (cold-induced urticaria),

exposure to ultraviolet light (solar urticaria), and exposure to water (aquagenic urticaria) 1,4. Despite the great number of possible etiologies, a large proportion of urticaria is idiopathic 1,2,4. Clinical Presentation and Classification We have already discussed the physical characteristics of an urticarial rash, but let s review it one more time. You are looking for pruritic, raised, red or pink skin lesions that have a pale wheal in the center. They may come in any shape or size. In 40% of cases, urticaria is accompanied by angioedema, which is swelling beneath the skin. Angioedema frequently presents as puffiness around the eyes and swelling of the lips and tongue. If urticaria is caused by allergic triggers, it can be accompanied by edema in the airway and difficulty breathing, which should be treated as an emergency 1,4. Please refer to the Pedscases podcast on anaphylaxis for a separate discussion on this topic. Let s go back to Jimmy. His mother describes his rash as bumpy and red, much like a bunch of mosquito bites. This rash sounds like urticaria so far, but your suspicions are confirmed when she pulls up some pictures on her phone. She also notes that he had very mild angioedema around his lips, but no stridor, cyanosis or other signs of difficulty breathing. Jimmy s urticaria can be categorized based on the timeline of his symptoms, and there are two time periods that we must distinguish. The first is the duration of time for which the individual lesions are present. Individual lesions of urticaria last for less than 48 hours, but recur. Lesions that remain for greater than 48 hours may indicate urticarial vasculitis, which indicates an inflammation of the skin blood vessels and is a more serious condition. We will talk more about this when we review the differential diagnosis 2,4. The second timeframe to determine is the total amount of time for which the episodes of urticaria have been occurring. If the rash has been present for most days of the week, for less than 6 weeks, we classify it as acute urticaria. If the rash has been present on most days of the week for 6 weeks or longer, we classify it as chronic urticaria. Chronic urticaria is much more common in the adult population, particularly in females 2,4. Although acute and chronic urticaria are both frequently idiopathic in nature, their etiologies do differ. Acute urticaria is usually secondary to infection, exposure to allergens and venoms, and medications. In contrast, chronic urticaria is often due to physical triggers or an autoimmune process 2,4.

Diagnosis A diagnosis of urticaria is based on a thorough history and physical examination. In your history, it is important to ask questions about the physical appearance of the rash. Describe the skin lesions in terms of size, shape, color, texture, and any associated skin changes. What is the distribution of the rash? Try to qualify the severity of the rash and its impact on the child s life. It is also necessary to clarify the two aspects of timing that we discussed earlier. How long do the skin lesions last? How long has the rash been occurring as a whole? Next, ask whether any triggers have already been identified. If not, go through the most common causes in a systematic fashion, asking about recent infections, new exposures to potential allergens, venoms, new medications, physical triggers and autoimmune symptoms 1,2. It may also be beneficial to inquire into a personal or family history of the atopic triad, which consists of eczema, asthma and allergic rhinitis. Allergies travel in packs, and these individuals tend to have a genetic pre-disposition to develop IgE mediated responses to environmental triggers 2. A physical examination can be helpful in diagnosing urticaria. Start with vital signs if you have any concerns that the child is unstable. As with any child, examine the cardiovascular, respiratory, gastrointestinal, and ENT systems. Next, move on to a thorough exam of the skin. If the rash is present at the time of the visit, describe the morphology, distribution, and whether it is painful or pruritic. If the rash isn t present, you can ask the parents if they have any pictures. Check for any yellow or tan pigmented lesions which can indicate urticaria pigmentosa, a form of cutaneous mastocytosis 7. In many patients, a history and physical are enough for a diagnosis of urticaria. If the history is ambiguous and insufficient for a diagnosis, select additional investigations may be warranted. When considering physical urticaria, it is possible to expose the patient to a physical stimulus and watch for a reaction. For example, dermatographism can be confirmed by applying light pressure on the back with a tongue depressor, then watching for hives to form in the same pattern. If you suspect that there is an allergic trigger for the urticaria, skin prick testing and serum IgE testing may be done. If you suspect an autoimmune origin, serum protein electrophoresis (SPE) can confirm the presence of autoantibodies. An autologous serum skin test (ASST), is essentially a skin prick test with the patient s own serum, and can also reveal a reaction. Again, none of these tests are routinely done and you should refer the patient to an allergist at this stage 1,2. Let s revisit Jimmy. You ask his mother about any possible triggers, and she mentions that Jimmy has been having some upper respiratory tract infections symptoms of runny

nose and cough for a few days. He has been afebrile so she has not given him any NSAIDs, but she did give him some kids Claritin for the rash, which up within an hour. He is otherwise healthy, and does not take any medications or have any known allergies. You suspect that he may have a viral URTI which led to his urticaria, and decide that no investigations are warranted. Differential Diagnoses There are many other diagnoses that must be considered in a patient presenting with rash. The nature of the rash will narrow this list down, as a vesicular or painful rash likely points to an infectious agent like varicella or coxsackie virus. Chronic atopic dermatitis will result in dry and thickened skin around the rash. Symmetric, target lesions which progress in a distal to proximal manner are more indicative of erythema multiforme minor, a T-cell mediated type IV hypersensitivity reaction 2,8. If the patient is presenting with a rash characteristic of urticaria, but it is painful and lasts more than 48 hours, consider urticarial vasculitis. Urticarial vasculitis is an autoimmune inflammatory condition of small blood vessels. You should also consider urticaria pigmentosa if you see pruritic lesions that are yellow to brown, or localized hives form after rubbing the skin (also known as Darier s sign). Urticaria pigmentosa is a common manifestation of both cutaneous and systemic mastocytosis 4,7. Management of Urticaria Management of acute and chronic urticaria relies on avoidance of triggers and antihistamines. In some cases, avoidance of triggers is not sufficient to control the urticaria, or there are no known triggers to avoid. At this point, regular use of second generation, non-sedating H1 receptor antihistamines is the first-line management. These include fexofenadine, desloratadine, loratadine, levocetirizine, cetirizine, bilastine and rupatidine. Try to avoid first generation H1 receptor antihistamines as they are sedating. If a patient is not responsive to the initially prescribed antihistamine, it is worth trying another in the same class or increasing the dose by up to 4 times the usual. If that still does not provide relief, adjunct therapies can be added in the form of H2 receptor antihistamines like cimetidine, ranitidine, and nizatidine, or leukotriene receptor antagonists such as montelukast 1,2,4. Patients with severe chronic urticaria that is refractory to treatment should be referred to an allergist or dermatologist, who may titrate them on immunosuppressive and immunomodulatory therapies. The treatment of choice is omalizumab (an anti-ige monoclonal antibody), but cyclosporine, sulfasalazine, IVIG, and dapsone are also possible options. In the short term, severe and unresponsive symptoms may be treated with a 3-10 day course of oral corticosteroids. This is uncommon and not treated as the

standard because of the serious side effects of steroids, and a risk of relapse once they are stopped 1,2. Approximately a third of patients with chronic urticaria will have spontaneous resolution of symptoms within a year, and another third will experience improvement in their symptoms. Patients with chronic idiopathic urticaria do better in terms of symptom resolution than those with chronic physical urticaria 1,4. Let s re-visit Jimmy one last time. His mother wants to know how to stop this from happening again. You tell her that although there is no way to prevent the urticaria from returning, she can provide symptomatic relief. You tell her she can continue to use loratadine as needed, and reinforce that she should avoid Benadryl as it is sedating. Summary We ve reached the end of this PedsCases podcast, so it s time for a quick recap. Here are some take-home points to remember: 1. Urticaria, commonly known as hives, is characterized by a pruritic rash. The rash consists of red, raised lesions with pale centers. The shape and size of the lesions may vary. 2. Urticaria results from degranulation of mast cells and basophils. 3. Urticaria that has been present for fewer than 6 weeks is classified as acute, whereas urticaria that has been present for greater than 6 weeks is classified as chronic. 4. Half of acute urticaria cases are idiopathic. Other common etiologies include viral infections, allergens, medications, and bacterial and parasitic infections. 5. Most chronic urticaria is also idiopathic. Other common etiologies incude autoimmune processes and physical stimuli. 6. The first line management for urticaria is avoidance of triggers and regular use of second-generation, non-sedating, H1 antihistamines. Thank you for listening to this PedsCases podcast. Stay tuned for more! References 1. Schaefer P. Acute and Chronic Urticaria: Evaluation and Treatment. 2017;95(11). 2. Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy, Asthma Clin Immunol. 2011;7(Suppl 1):S9. doi:10.1186/1710-1492-7-s1-s9. 3. Barbara A. Muller. Urticaria and Angioedema: A Practical Approach. Am Fam Physician. 2004;69(5):1123-1128. 4. Deacock SJ. An approach to the patient with urticaria. Clin Exp Immunol. 153(2).

5. Swain AR, Dutton SP, Truswell AS. Salicylates in foods. J Am Diatetic Assoc. 1985;85(8):950-960. 6. Kurowski K, Boxer RW. Food Allergies: Detection and Management. 2008;77(12). 7. William A. Alto. Cutaneous and Systemic Manifestations of Mastocytosis. Am Fam Physician. 1999;59(11):3047. 8. Michele R., Sternbach MR, Hsu WT. Erythema Multiforme. Am Fam Physician. 2006;74(11):1883-1888.